Literature DB >> 31701797

Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.

Alex Ghanouni1, Saskia C Sanderson2, Nora Pashayan3, Cristina Renzi1, Christian von Wagner1, Jo Waller1.   

Abstract

OBJECTIVES: Risk stratification may improve the benefit/harm ratio of breast screening. Research on acceptability among potential invitees is necessary to guide implementation. We assessed women's attitudes towards and willingness to undergo risk assessment and stratified screening.
METHODS: Women in England aged 40-70 received summary information about the topic, and completed face-to-face computer-assisted interviews. Questions assessed willingness to undergo multifactorial breast cancer risk assessment, more frequent breast screening (if at very high risk), or less frequent or no screening (if at very low risk), and preferences for delivery of assessment results.
RESULTS: Among 933 women, 85% considered breast cancer risk assessment a good idea, and 74% were willing to have it. Among 125 women unwilling to have risk assessment, reasons commonly related to 'worry' (14%) and 'preferring not to know' (14%). Among those willing to have risk assessment (n = 689), letters/emails were generally preferred (42%) for results about very low-risk status. Face-to-face communication was most commonly preferred for results of very high-risk status (78%). General practitioners were most commonly preferred sources of assessment results (≈40%). Breast cancer specialists were often preferred for results of very high-risk status (38%). Risk-stratified breast screening was considered a good idea by 70% and 89% were willing to have more frequent screening. Fewer would accept less (51%) or no screening (37%) if at very low risk.
CONCLUSIONS: Women were generally in favour of multifactorial breast cancer risk assessment and risk-stratified screening. Some were unwilling to accept less or no screening if at very low risk.

Entities:  

Keywords:  Breast neoplasms; attitude; mass screening; risk assessment; surveys and questionnaires

Mesh:

Year:  2019        PMID: 31701797     DOI: 10.1177/0969141319883662

Source DB:  PubMed          Journal:  J Med Screen        ISSN: 0969-1413            Impact factor:   2.136


  13 in total

Review 1.  The future of early cancer detection.

Authors:  Rebecca C Fitzgerald; Antonis C Antoniou; Ljiljana Fruk; Nitzan Rosenfeld
Journal:  Nat Med       Date:  2022-04-19       Impact factor: 87.241

2.  Implementation considerations for offering personal genomic risk information to the public: a qualitative study.

Authors:  Amelia K Smit; Gillian Reyes-Marcelino; Louise Keogh; Kate Dunlop; Ainsley J Newson; Anne E Cust
Journal:  BMC Public Health       Date:  2020-06-29       Impact factor: 3.295

3.  The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.

Authors:  Victoria G Woof; Helen Ruane; David P French; Fiona Ulph; Nadeem Qureshi; Nasaim Khan; D Gareth Evans; Louise S Donnelly
Journal:  BMC Cancer       Date:  2020-05-20       Impact factor: 4.430

4.  Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.

Authors:  Victoria G Woof; Lorna McWilliams; Louise S Donnelly; Anthony Howell; D Gareth Evans; Anthony J Maxwell; David P French
Journal:  Womens Health (Lond)       Date:  2021 Jan-Dec

5.  Women's Views on Multifactorial Breast Cancer Risk Assessment and Risk-Stratified Screening: A Population-Based Survey from Four Provinces in Canada.

Authors:  Cynthia Mbuya Bienge; Nora Pashayan; Jennifer D Brooks; Michel Dorval; Jocelyne Chiquette; Laurence Eloy; Annie Turgeon; Laurence Lambert-Côté; Jean-Sébastien Paquette; Emmanuelle Lévesque; Julie Hagan; Meghan J Walker; Julie Lapointe; Gratien Dalpé; Palmira Granados Granados Moreno; Kristina Blackmore; Michael Wolfson; Yann Joly; Mireille Broeders; Bartha M Knoppers; Anna M Chiarelli; Jacques Simard; Hermann Nabi
Journal:  J Pers Med       Date:  2021-02-02

Review 6.  The current status of risk-stratified breast screening.

Authors:  Ash Kieran Clift; David Dodwell; Simon Lord; Stavros Petrou; Sir Michael Brady; Gary S Collins; Julia Hippisley-Cox
Journal:  Br J Cancer       Date:  2021-10-26       Impact factor: 9.075

7.  Extending screening intervals for women at low risk of breast cancer: do they find it acceptable?

Authors:  Lorna McWilliams; Victoria G Woof; Louise S Donnelly; Anthony Howell; D Gareth Evans; David P French
Journal:  BMC Cancer       Date:  2021-05-29       Impact factor: 4.430

8.  Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.

Authors:  Lorna McWilliams; Victoria G Woof; Louise S Donnelly; Anthony Howell; D Gareth Evans; David P French
Journal:  BMC Cancer       Date:  2020-07-22       Impact factor: 4.430

9.  Dutch women's intended participation in a risk-based breast cancer screening and prevention programme: a survey study identifying preferences, facilitators and barriers.

Authors:  Linda Rainey; Daniëlle van der Waal; Mireille J M Broeders
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

Review 10.  Personalized early detection and prevention of breast cancer: ENVISION consensus statement.

Authors:  Nora Pashayan; Antonis C Antoniou; Urska Ivanus; Laura J Esserman; Douglas F Easton; David French; Gaby Sroczynski; Per Hall; Jack Cuzick; D Gareth Evans; Jacques Simard; Montserrat Garcia-Closas; Rita Schmutzler; Odette Wegwarth; Paul Pharoah; Sowmiya Moorthie; Sandrine De Montgolfier; Camille Baron; Zdenko Herceg; Clare Turnbull; Corinne Balleyguier; Paolo Giorgi Rossi; Jelle Wesseling; David Ritchie; Marc Tischkowitz; Mireille Broeders; Dan Reisel; Andres Metspalu; Thomas Callender; Harry de Koning; Peter Devilee; Suzette Delaloge; Marjanka K Schmidt; Martin Widschwendter
Journal:  Nat Rev Clin Oncol       Date:  2020-06-18       Impact factor: 65.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.